Showing results (71-80 of 824) with videos related to

Sort By:
Pageof 83
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Cancer Research|January 9, 2003
Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase proteinMasaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, et al.
Seminars in Hematology|April 25, 2009
Emerging treatments for multiple myeloma: beyond immunomodulatory drugs and bortezomibConstantine S Mitsiades, Teru Hideshima, Dharminder Chauhan, et al.
British Journal of Haematology|July 8, 2011
Managing multiple myeloma: the emerging role of novel therapies and adapting combination treatment for higher risk settingsPaul G Richardson, Jacob Laubach, Constantine S Mitsiades, et al.
Cancer Research|July 5, 2002
Cytokines modulate telomerase activity in a human multiple myeloma cell lineMasaharu Akiyama, Teru Hideshima, Toshiaki Hayashi, et al.
The Journal of Biological Chemistry|March 11, 2004
Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cellsKlaus Podar, Gustavo Mostoslavsky, Martin Sattler, et al.
Blood|January 19, 2006
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cellsTeru Hideshima, Laurence Catley, Hiroshi Yasui, et al.
Cancer Research|September 17, 2005
A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cellsDharminder Chauhan, Guilan Li, Klaus Podar, et al.
Blood|April 14, 2005
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myelomaNoopur Raje, Shaji Kumar, Teru Hideshima, et al.
Blood|December 10, 2013
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistanceZe Tian, Padraig D'Arcy, Xin Wang, et al.
Pageof 83